- Home
- TGB vs ARCT Comparison
TGB vs ARCT Comparison
Compare TGB & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGB
- ARCT
- Stock Information
- Founded
- TGB 1966
- ARCT 2013
- Country
- TGB Canada
- ARCT United States
- Employees
- TGB N/A
- ARCT N/A
- Industry
- TGB Precious Metals
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- TGB Basic Materials
- ARCT Health Care
- Exchange
- TGB Nasdaq
- ARCT Nasdaq
- Market Cap
- TGB 584.6M
- ARCT 487.0M
- IPO Year
- TGB N/A
- ARCT N/A
- Fundamental
- Price
- TGB $1.94
- ARCT $16.36
- Analyst Decision
- TGB Strong Buy
- ARCT Strong Buy
- Analyst Count
- TGB 1
- ARCT 8
- Target Price
- TGB $3.50
- ARCT $61.00
- AVG Volume (30 Days)
- TGB 4.2M
- ARCT 405.9K
- Earning Date
- TGB 03-06-2025
- ARCT 03-06-2025
- Dividend Yield
- TGB N/A
- ARCT N/A
- EPS Growth
- TGB 207.78
- ARCT N/A
- EPS
- TGB 0.12
- ARCT N/A
- Revenue
- TGB $439,681,705.00
- ARCT $160,399,000.00
- Revenue This Year
- TGB $18.19
- ARCT $7.33
- Revenue Next Year
- TGB $19.11
- ARCT $4.71
- P/E Ratio
- TGB $16.72
- ARCT N/A
- Revenue Growth
- TGB 39.36
- ARCT N/A
- 52 Week Low
- TGB $1.34
- ARCT $14.30
- 52 Week High
- TGB $3.15
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- TGB 47.57
- ARCT 45.85
- Support Level
- TGB $1.77
- ARCT $15.34
- Resistance Level
- TGB $1.97
- ARCT $17.95
- Average True Range (ATR)
- TGB 0.08
- ARCT 1.17
- MACD
- TGB -0.00
- ARCT -0.08
- Stochastic Oscillator
- TGB 58.62
- ARCT 39.08
About TGB Taseko Mines Ltd.
Taseko Mines Ltd is a Canadian mining company. It is principally engaged in the production and sale of metals, as well as related activities, including exploration and mine development, within the province of British Columbia, Canada, and the State of Arizona, the United States. The Gibraltar, Aley, New Prosperity, Yellowhead properties are located in British Columbia whereas Florence copper is in central Arizona.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.